| 4:00–8:00 PM | Registration |
| 6:00–8:00 PM | Welcome Mixer |
| 7:00–8:00 AM | Breakfast |
| 7:30–8:00 AM | Poster Setup |
| 7:45–5:00 PM | Poster Viewing |
| 8:00–8:10 AM | Welcome Remarks |
| 8:10–9:00 AM | Keynote Address (Sponsored by Eli Lilly) |
| * Karin Bok, Eli Lilly Chair Introduction |
| Bali Pulendran, Stanford University School of Medicine Next Generation Immune Inspired Vaccine Design |
| 9:00–11:15 AM | How Can We Overcome Waning and Imprinted Immunity? |
| Robert A. Seder, NIAID, National Institutes of Health Anamnestic Immunity - The Key to Durability |
| Adolfo García-Sastre, Mount Sinai School of Medicine Breaking the Imprint |
| Dan H. Barouch, Beth Israel Deaconess Medical Center Vaccine Immunity to Respiratory Pathogens |
| Yael Weiss-Ottolenghi †, Sheba Medical Center, Tel-Hashomer, Israel Short Talk: Profiling the Serological Dynamics Following Seasonal Respiratory Viral Infections in Healthcare Workers |
| 9:30–9:50 AM | Coffee Break |
| 11:15–12:15 PM | Lunch |
| 12:00–2:30 PM | Poster Session 1 |
| 3:00–4:30 PM | Panel 1: Is a One Size Fits All Vaccine Possible for All Populations |
| * Galit Alter, AstraZeneca |
| * Christopher Chiu, Imperial College London |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Dissecting and Harnessing the GC Response? |
| Gabriel D Victora, Rockefeller University/HHMI Refueling germinal center reactions by boosting |
| Michela Locci, University of Pennsylvania Dissecting the GC Response |
| Carola G Vinuesa, Francis Crick Institute Driving Productive Extra and Intra Follicular B Cell Immunity |
| Casey Beppler †, Stanford University Short Talk: Aging Restricts Maturation of CXCL13⁺ Tfh Cells in Human Immunity |
| Madison L Seefeld †, University of Minnesota Short Talk: Albumin Hitch-hiking Vaccines for Protection against Herpes Simplex Virus |
| 7:00–8:00 PM | On Own for Dinner |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:30 AM | How Can We Use Correlates and AI to Accelerate Vaccine Development? |
| Galit Alter, AstraZeneca Advancing Platform Level Correlates of Immunity |
| John Tsang, Yale University School of Medicine AI & Systems Immunology for Vaccine Development |
| Lisa Wagar, University of California, Irvine Modeling Vaccine Induced Immunity to Drive Vaccine Design |
| Francis Impens, Ghent University T Cell Epitope Discovery based AMR Vaccines |
| Jishnu Das †, University of Pittsburgh Short Talk: A Systems Approach to Discover Viral Evolutionary Constraints Essential For Hijacking Host Cellular Machinery To Design Broadly Neutralizing Immunotherapies |
| Marjolein Stip †, RIVM (Dutch Institute for Public Health and Environment) Short Talk: The Contribution of Pre-existing, Broadly Reactive T cells in Heterosubtypic Protection against A(H1N1)pdm09 Infection in Children |
| Bryant S Colin †, University of Chicago Short Talk: Scalable Transcriptional Profiling of CD4+ T Cell States for Vaccine and Adjuvant Discovery |
| Gitte Erbs †, Statens Serum Institut Short Talk: Identification of Immunological Correlates of Protection (CoP) in the Helicobacter Pylori Mouse Challenge Model |
| 9:00–9:20 AM | Coffee Break |
| 9:20–9:25 AM | Award Recipient Acknowledgement |
| 11:30–1:00 PM | Poster Setup |
| 11:30–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 2:30–3:30 PM | Career Roundtable |
| 3:30–4:30 PM | Panel on Structure-Based Vaccine Design |
| Joel Finney †, Boston Children's Hospital Short Talk: A Public Class of Broadly Protective Human Antibodies that Bind Postfusion Influenza Hemagglutinin |
| Anna-Sophia Boguraev †, Harvard University Short Talk: Computationally Designed Scaffolds Present Complex Flavivirus Epitopes |
| Dieter Sebastian Hoffmann, Leipzig University Short Talk: Germline-targeting Hepatitis C Virus Immunogens with broad affinity for precursors of AR3C-Class Broadly Neutralizing Antibodies |
| Danton Ivanochko †, The Hospital for Sick Children Short Talk: A Stabilized Tandem Antigen Chimera that Elicits Potent Malaria Transmission-Reducing Activity |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | How Can We Exploit New Platforms to Accelerate Vaccine Development and Global Equity? |
| Lynda M. Stuart, Fund for Science and Technology (Paul Allen Foundation) Mimicking Pathogen Shape to Train the Immune Response |
| Annaliesa S. Anderson, Pfizer, Inc Next Generation Vaccines for Bacteria |
| Anna Rydlova †, Imperial College London Short Talk: Interrogating Humoral Immune Features Beyond O-Antigen–Specific IgG in a Human Non-Typhoidal Salmonella Challenge Model |
| Courtney R. Plumlee †, Seattle Children's Research Institute Short Talk: Prevention of Infection in an Ultra-low Dose Tuberculosis Murine Model is a Novel Metric of Vaccine-Mediated Immunity |
| Luka Cicin-Sain †, Helmholtz Centre for Infection Research Short Talk: Xenotropic Latency of a Non-replicating Herpesviral Vaccine Vector Elicits Lasting Adaptive Immunity |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Poster Session 2 |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Do We Need Tissue Resident Immunity to Achieve Mucosal Protection? |
| Christopher Chiu, Imperial College London The Power of the Human Challenge Model |
| Daniela M Ferreira, University of Oxford Dissecting Mucosal Correlates to Bacterial Pathogens |
| Mihai L Azoitei †, Duke University AI-Powered Immunogen Design to Target Conserved Regions of Rapidly Evolving Pathogens |
| Donna L Farber, Columbia University Medical Center Tissue Resident T Cells across Organs |
| Haibo Zhang †, Stanford University Short Talk: Mucosal Vaccination Transcends Pathogen Boundaries to Protect from Diverse Respiratory Threats |
| Dong-il Kwon †, Yale University, School of Medicine Short Talk: Clonal Expansion and Trafficking of Memory B Cells Underpin Bone Marrow and Lung IgA+ Plasma Cells following Unadjuvanted Nasal Booster Administration |
| 9:00–9:20 AM | Coffee Break |
| 11:00–5:00 PM | On Own for Lunch |
| 11:30–1:00 PM | Poster Setup |
| 1:00–10:00 PM | Poster Viewing |
| 3:00–4:30 PM | Panel 2: Vaccine Equity and Global Health |
| * Lynda M. Stuart, Fund for Science and Technology (Paul Allen Foundation) |
| * Dan H. Barouch, Beth Israel Deaconess Medical Center |
| 4:30–5:00 PM | Coffee Available |
| 5:00–6:45 PM | How Does Immunology Inform Next Generation Therapeutic Vaccine Design? |
| Ari Waisman, University of Mainz, Medical School Tolerizing Vaccines to Fight Autoimmunity |
| Michal Bassani-Sternberg, University Hospital of Lausanne, Ludwig Institute for Cancer Research Inspiring Cancer Vaccine Design with Immunopeptidomics |
| Meklit Workneh, Moderna Norovirus Vaccines |
| Audrey K Thomas, Vanderbilt University Short Talk: Mucosal Vaccination Clears Clostridioides Difficile Colonization |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Poster Session 3 |
| 12:00–11:59 PM | Departure |